Health Care Equipment & Services

Agilon Health faces a Pomerantz investigation over alleged misrepresentations, sparking a 90 % share decline and prompting governance reforms.

iSpecimen Inc.

Ekso Bionics faces a sharp 13% share plunge after announcing it will exclusively distribute a new robotic exoskeleton platform, raising investor doubts about its growth prospects.

Discover how Luyan Pharma’s strong market cap, 52‑week stability, and 26.5 P/E position it as a key medical distributor in China’s healthcare supply chain.

Dogecoin Cash Inc. blends herbal‑care staples with meme‑coin buzz—explore how DOGE’s $0.17‑$0.19 rally could temporarily lift a $3 M OTC stock while its modest fundamentals linger.

WORK Medical Technology Group’s 1‑for‑100 reverse stock split aims to stabilize its stock amid steep volatility and restore investor confidence.

Huadong Medicine partners with Chance Pharma to launch respiratory drug CXG87, boosting its portfolio and stock stability amid a 21.7% annual range.

Teladoc Health’s stock has slid 52% from its 2025 peak, reflecting a negative P/E and below‑book valuation, yet telehealth demand keeps the company in focus for investors.

Co‑Diagnostics Inc. thrives amid market volatility, offering niche nucleic‑acid reagents and lab systems while advancing TB diagnostics through a joint venture.

Dogecoin Cash Inc’s OTC stock trades at $0.0182—an undervalued niche player in cannabis‑derived personal care amid crypto volatility that may dampen liquidity but offers a natural‑product advantage for long‑term growth.